Paying 30x this year's free cash flow for Doximity represents a fantastic buying opportunity, particularly as the stock is poised to hit $55 by the end of 2025.
The company’s debt-free balance sheet, coupled with robust cash generation and a Rule of 50 performance, makes it an undervalued gem in the SaaS space. While it may not have the hyper-growth appeal of other tech stocks, its solid fundamentals, steady revenue growth, and strong client retention indicate long-term value creation.
As investors realize its true potential, I expect the stock to gain significant momentum in the coming months.